We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA has revised its Emergency Use Authorization (EUA) for COVID-19 convalescent plasma, allowing only plasma with high antibody titers and only for hospitalized patients with early infections or patients with impaired immunity. Read More
The European Medicines Agency (EMA) is reviewing Eli Lilly’s antibody cocktail as a potential treatment for COVID-19 patients who don’t require supplemental oxygen and are at high risk of progressing to severe disease. Read More
As U.S. vaccinations against COVID-19 gain momentum, health officials are using new tools to gather postmarket safety data, including a new early warning system called V-Safe. Read More
The FDA intends to publish draft guidance in the next several weeks outlining the data it will require for modifying authorized vaccines to address new COVID-19 viral variants, according to FDA Acting Commissioner Janet Woodcock. Read More
Consulting giant McKinsey has agreed to pay $573.9 million to settle a lawsuit brought by the attorneys general of 49 states, the District of Columbia and five U.S. territories over work it did for opioid painkiller manufacturers. Read More
The COVAX vaccine program aims to distribute almost 340 million vaccine doses during the first half of the year, according to its latest distribution plan unveiled yesterday. Read More
Moderna said it is in discussions with the FDA over a proposal to fill its COVID-19 vaccine vials with up to 50 percent more doses to help increase the pace of inoculations in the U.S. Read More
The FDA’s Center for Biologics Evaluation and Research (CBER) has published its list of draft and final guidances that it aims to develop in 2021. Read More
The Pharmaceutical Research and Manufacturers of America (PhRMA) is calling on the World Trade Organization (WTO) to reject a proposal that would temporarily revoke patents for COVID-19 vaccines and treatments, ahead of a WTO meeting on intellectual property scheduled for tomorrow. Read More
The federal government could invoke a clause of patent law designed for wartime to use drug companies’ intellectual property to combat the COVID-19 pandemic, says an attorney experienced in this area — while others say the same tool could help the government lower drug prices. Read More
AstraZeneca (AZ) has promised to deliver an additional 9 million doses of its vaccine to EU member states during the first quarter of this year, bringing its total delivery for the period up to 40 million — but still only half of the initial 80 million-dose commitment in its contract with the bloc. Read More